Try our Advanced Search for more refined results
March 12, 2010
Sabbagh v. Cell Therapeutics Inc et al
Case Number:
2:10-cv-00414
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
- Brower Piven
- Fox Rothschild
- Hagens Berman
- Kahn Swick
- Karr Tuttle
- Keller Rohrback
- Kessler Topaz
- Lane Powell
- Lieff Cabraser
- O'Melveny & Myers
- Robbins Geller
- Ropes & Gray
- Wilk Auslander
- Wilson Sonsini
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
February 14, 2012
Cell Therapeutics Settles Investor Lawsuit For $19M
Seattle-based biotechnology company Cell Therapeutics Inc. agreed to pay $19 million to settle a class action by investors who contended the company's stock price was artificially inflated due to misleading statements about a pipeline drug, according to a Tuesday court filing.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login